On March 28, 2024, the Johns Hopkins Center for Mental Health and Addiction Policy and the White House Office of National Drug Control Policy hosted a forum about recent rules and guidance issued by the Substance Abuse & Mental Health Services Administration (SAMHSA) on the use of methadone in correctional facilities and the concurrent roll-out of federal initiatives increasing access to treatment. We're proud to present the program in full here, including panel discussions with policymakers and practitioners at the federal, state and local levels.
Featured speakers included:
Rahul Gupta, MD, MPH, FACP, MBA
Director of the White House Office of National Drug Control Policy (ONDCP)
Brendan Saloner, PhD
Bloomberg Professor of American Health
Johns Hopkins Bloomberg School of Public Health
Yngvild Olsen, MD, MPH
Director of the Center for Substance Abuse Treatment (CSAT)
Substance Abuse & Mental Health Services Administration (SAMHSA)
Matthew Strait, MA
Deputy Assistant Administrator
Office of Diversion Control Regulatory (DCR)
Drug Enforcement Administration (DEA)
Sara Whaley, MPH, MSW, MA
Senior Practice Associate
Johns Hopkins Bloomberg School of Public Health
Catherine Smith, DO
Director of Addiction Medicine
Washington State Department of Corrections
Ryan Thornell, PhD
Director
Arizona Department of Corrections Rehabilitation and Reentry
For more information about how access to methadone treatment can be implemented in carceral settings, check out these links:
